TABLE 4.
Aminoglycosides | Carbapenem | Inhibitor | Antibiotics + inhibitors | Cephalosporins | |||
---|---|---|---|---|---|---|---|
Strain/symbol | GEN (mm) | SPC (mm) | IMI (mm) | TET (mm) | PTZ (mm) | CAZ (mm) | Phenotype |
1 | S (16) | S (18) | R (12) | R (14) | R (15) | R (11) | MDR** |
2 | S (17) | S (17) | I (18) | I (20) | I (19) | S (18) | Non‐MDR |
3 | S (16) | S (17) | I (19) | S (21) | I (18) | I (16) | Non‐MDR |
4 | S (18) | S (18) | I (18) | I (19) | I (21) | S (18) | Non‐MDR |
5 | S (15) | S (17) | R (13) | R (13) | R (12) | R (12) | MDR** |
6 | S (17) | S (19) | I (21) | S (21) | I (18) | I (17) | Non‐MDR |
7 | S (17) | S (17) | R (14) | R (14) | R (13) | R (10) | MDR** |
ATCC 29545 | S (18) | S (17) | S (22) | S (24) | S (23) | S (19) | Non‐MDR |
Detection range | S: ≥15 | S: ≥17 | S: ≥22 | S: ≥21 | S: ≥21 | S: ≥18 | S = sensitive |
R: 12 ≥ | R: 14 ≥ | R: 18≥ | R: 17≥ | R: 17 ≥ | R: 14 ≥ | R = resistant | |
I = Intermediate |